Crossmark

Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery

Crossref DOI link: https://doi.org/10.1007/s11845-014-1135-y

Published Online: 2014-05-31

Published Print: 2015-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mongan, A. M.

Kalachand, R.

King, S.

O’Farrell, N. J.

Power, D.

Ravi, N.

Muldoon, C.

O’Byrne, K.

Reynolds, J. V.
License Information

Text and Data Mining valid from 2014-05-31